Skip to main content

Fisher HealthCare to Distribute Osmetech Products

NEW YORK (GenomeWeb News) – Osmetech today said that Thermo Fisher Scientific division Fisher HealthCare will distribute its eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the US.

The distribution agreement has a term of five years. Financial and other details were not disclosed.

"As we roll out our esensor XT-8 platform, Fisher Healthcare's considerable sales and marketing strength and established relationship with key customer accounts will play an important role in accelerating our market penetration," Osmetech CEO James White said in a statement.

Last July, Osmetech received US Food and Drug Administration 510(k) clearance for the eSensor platform and for its warfarin sensitivity test.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.